{"id":107737,"date":"2026-06-14T16:53:17","date_gmt":"2026-06-14T16:53:17","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/107737\/"},"modified":"2026-06-14T16:53:17","modified_gmt":"2026-06-14T16:53:17","slug":"novos-wegovy-pill-wins-approval-in-uk-for-obesity-treatment","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/107737\/","title":{"rendered":"Novo\u2019s Wegovy Pill Wins Approval in UK for Obesity Treatment"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">Novo Nordisk A\/S\u2019s Wegovy pill was approved in the UK, opening up the obesity market to people who are wary of taking a shot.<\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">The pill is authorized for adults with a body mass index of 30 or above, or who have a BMI of 27 to 30 with one other weight-related condition, the <a href=\"https:\/\/www.gov.uk\/government\/organisations\/medicines-and-healthcare-products-regulatory-agency\" title=\"Website\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Medicines and Healthcare products Regulatory Agency<\/a> said Thursday. The approval will allow the products to be sold to private patients and via telehealth providers, and Novo said it should be available within weeks.<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk A\/S\u2019s Wegovy pill was approved in the UK, opening up the obesity market to people who&hellip;\n","protected":false},"author":2,"featured_media":107738,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[438,16167,71,1585,53684,286,54628,272,13578,685,38700,5230,294],"class_list":["post-107737","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-business","tag-eli-lilly-co","tag-europe","tag-government","tag-great-britain","tag-markets","tag-national-health-service","tag-novo-nordisk","tag-novo-nordisk-a-s-b","tag-regulation","tag-telemedicine","tag-united-arab-emirates","tag-united-kingdom"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116749507394867719","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/107737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=107737"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/107737\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/107738"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=107737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=107737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=107737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}